| Primary |
| Rheumatoid Arthritis |
46.2% |
| Juvenile Arthritis |
27.6% |
| Drug Use For Unknown Indication |
11.1% |
| Pre-existing Disease |
2.3% |
| Still's Disease Adult Onset |
2.3% |
| Chronic Infantile Neurological Cutaneous And Articular Syndrome |
1.7% |
| Polyarthritis |
1.7% |
| Juvenile Idiopathic Arthritis |
0.9% |
| Drug Level |
0.7% |
| Osteoarthritis |
0.7% |
| Systemic Lupus Erythematosus |
0.7% |
| Schnitzler's Syndrome |
0.6% |
| Muckle-wells Syndrome |
0.5% |
| Psoriatic Arthropathy |
0.5% |
| Vasculitis |
0.5% |
| Arthritis |
0.4% |
| Gout |
0.4% |
| Acute Myocardial Infarction |
0.3% |
| Histiocytosis Haematophagic |
0.3% |
| Product Used For Unknown Indication |
0.3% |
|
| Injection Site Reaction |
10.5% |
| Rheumatoid Arthritis |
10.2% |
| Injection Site Pain |
9.9% |
| Urticaria |
9.0% |
| Rash |
8.1% |
| Pyrexia |
7.5% |
| Vomiting |
6.0% |
| Injection Site Swelling |
5.7% |
| Rash Generalised |
3.6% |
| Death |
3.3% |
| Injection Site Rash |
3.3% |
| Injection Site Warmth |
3.0% |
| Skin Cancer |
3.0% |
| Nausea |
2.7% |
| Pain |
2.7% |
| Staphylococcal Infection |
2.7% |
| Sepsis |
2.4% |
| Varicella |
2.4% |
| Drug Ineffective |
2.1% |
| Histiocytosis Haematophagic |
2.1% |
|
| Secondary |
| Rheumatoid Arthritis |
34.9% |
| Drug Use For Unknown Indication |
24.0% |
| Juvenile Arthritis |
18.9% |
| Diffuse Vasculitis |
4.3% |
| Product Used For Unknown Indication |
3.5% |
| Hypertension |
1.8% |
| Osteoporosis |
1.5% |
| Still's Disease Adult Onset |
1.5% |
| Vasculitis |
1.5% |
| Antibiotic Prophylaxis |
0.9% |
| Goitre |
0.9% |
| Pain |
0.9% |
| Stomatitis |
0.9% |
| Essential Hypertension |
0.7% |
| Pre-existing Disease |
0.7% |
| Rash |
0.7% |
| Type 1 Diabetes Mellitus |
0.7% |
| Atrial Fibrillation |
0.5% |
| Furuncle |
0.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.5% |
|
| Myocardial Infarction |
9.2% |
| Hodgkin's Disease |
8.0% |
| Parvovirus Infection |
8.0% |
| Non-small Cell Lung Cancer |
6.9% |
| Vomiting |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Obesity |
5.7% |
| Lymphoma |
4.6% |
| Pleural Effusion |
4.6% |
| Rash Erythematous |
4.6% |
| Drug Ineffective |
3.4% |
| Hodgkin's Disease Stage Ii |
3.4% |
| Leukopenia |
3.4% |
| Lung Adenocarcinoma |
3.4% |
| Lung Neoplasm Malignant |
3.4% |
| Malignant Melanoma |
3.4% |
| Neutropenia |
3.4% |
| Post Transplant Lymphoproliferative Disorder |
3.4% |
| Procedural Complication |
3.4% |
| Tuberculosis |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
40.2% |
| Rheumatoid Arthritis |
22.7% |
| Product Used For Unknown Indication |
11.0% |
| Osteoporosis |
3.3% |
| Juvenile Arthritis |
2.3% |
| Atrial Fibrillation |
2.1% |
| Hypertension |
2.1% |
| Juvenile Idiopathic Arthritis |
1.9% |
| Depression |
1.8% |
| Myocardial Infarction |
1.8% |
| Cardiac Failure |
1.5% |
| Chronic Infantile Neurological Cutaneous And Articular Syndrome |
1.5% |
| Antibiotic Prophylaxis |
1.1% |
| Pain |
1.1% |
| Furuncle |
1.0% |
| Goitre |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Stomatitis |
1.0% |
| Arthritis |
0.9% |
| Abdominal Pain Upper |
0.8% |
|
| Respiratory Failure |
8.2% |
| Arthropathy |
6.6% |
| Oedema Peripheral |
6.6% |
| Sepsis |
6.6% |
| Urticaria |
6.6% |
| Visual Disturbance |
6.6% |
| Weight Increased |
6.6% |
| Acute Generalised Exanthematous Pustulosis |
4.9% |
| Atrial Fibrillation |
4.9% |
| Intracranial Pressure Increased |
4.9% |
| Pyrexia |
4.9% |
| Systolic Dysfunction |
4.9% |
| Tremor |
4.9% |
| Arthrodesis |
3.3% |
| Cardiac Arrest |
3.3% |
| Cytomegalovirus Infection |
3.3% |
| Depression |
3.3% |
| Fatigue |
3.3% |
| Leukopenia |
3.3% |
| Medication Error |
3.3% |
|
| Interacting |
| Immune Reconstitution Syndrome |
42.9% |
| Hepatitis C |
28.6% |
| Depression |
14.3% |
| Thyroidectomy |
14.3% |
|
| Activities Of Daily Living Impaired |
50.0% |
| Somnolence |
50.0% |
|
